North America

A new analysis of FDA approvals.

You'd think any drug developed to help fight the pandemic would be affordable, right? Nope. Here's how Gilead plans to make billions in profits off human suffering.

By requiring hospitals to post real prices and insurers to disclose reimbursement rates, Congress can help patients and stimulate the economy.

In a 7-2 ruling in a case involving the Little Sisters of the Poor, the court said employers with a “religious or moral objection” to contraceptives should not be forced to insure women for those services.

The United States reported more than 60,000 new Covid-19 cases on Tuesday, setting a fresh record for new cases reported in a single day, according to data compiled by Johns Hopkins University.

Epidemiological data tracking the extent of the coronavirus outbreak and testing efforts.

It does appear that the Minnesota Legislature is going to have to come up with a new plan for providing insulin to people who can’t afford it.

A pandemic hasn’t stopped some pharma companies from implementing their traditional mid-year price hikes.

The U.S. government has signed a $450 million contract with Regeneron Pharmaceuticals Inc for its potential COVID-19 antibody cocktail.

Now more than ever, it is critical that both public and private assets can be brought to bear in addressing critical diseases such as COVID-19. Here’s what you need to know.

The U.S. government has provided Regeneron with $450 million contract to supply and manufacture its Covid-19 anti-viral antibody cocktail.

Pharmaceutical companies in the United States have logged more than 800 price increases this year.

From pharmacies in your network, coupons, discount programs, and even samples from your doctors – The Doctors share some great tips that just might help you save some money on your next trip to the drug store.

In a global pandemic characterized by extreme uncertainty, governments, employers and citizens have been flung into situations they weren’t fully prepared for.

Some Democratic lawmakers and policy experts attacked remdesivir's price as soon as it was announced.